Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
AIM ImmunoTech Inc. shareholders approved Ratification of the selection of BDO USA, LLP as the Company's independent auditors for the fiscal year ending December 31, 2022 at the 2022-11-03 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2022-11-03
Exact text from the filing
Ratification of the selection of BDO USA, LLP as the Company’s independent auditors for the fiscal year ending December 31, 2022 : For: 19,946,910 Against: 1,876,423 Abstain: 366,347
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
AIM ImmunoTech Inc. shareholders approved Election of Directors at the 2022-11-03 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2022-11-03
Exact text from the filing
Election of Directors : The following three director nominees were each elected to serve a term ending at the Company’s Annual Meeting of Stockholders for 2023, or until their successors are duly elected and qualified: Nominees For Withheld Broker Non-Votes Thomas K. Equels 7,652,988 4,705,546 9,831,146 William M. Mitchell 4,330,110 8,028,424 9,831,146 Stewart L. Appelrouth 4,319,085 8,039,449 9,831,146
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
AIM ImmunoTech Inc. shareholders rejected Approval, by non-binding vote, of executive compensation at the 2022-11-03 meeting.
- Proposal
- say on pay
- Outcome
- failed
- Meeting
- 2022-11-03
Exact text from the filing
Approval, by non-binding vote, of executive compensation : For: 2,036,994 Against: 10,213,253 Abstain: 108,287 Broker Non-Votes: 9,831,146
View on SEC.gov